CytomX Therapeutics CTMX EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's EV / sales?
- CytomX Therapeutics (CTMX) reported EV / sales of 27.9× in Q1 2026.
- How has CytomX Therapeutics's EV / sales changed year-over-year?
- CytomX Therapeutics's EV / sales increased by 35750.8% year-over-year, from 0.1× to 27.9×.
- What is the long-term trend for CytomX Therapeutics's EV / sales?
- Over 5 years (2020 to 2025), CytomX Therapeutics's EV / sales has grown at a 19.7% compound annual growth rate (CAGR), from 3.8× to 9.4×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.